Evidence map›Paper›PMID 36450767›Full record

ArticleNature communications2022

Perfluorodecalin-based oxygenated emulsion as a topical treatment for chemical burn to the eye.

Sanming Li, Kunpeng Pang, Shuyan Zhu, Kathryn Pate, Jia Yin

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sanming LiSchepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Department of Ophthalmology, Boston, MA, USA.
Kunpeng PangSchepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Department of Ophthalmology, Boston, MA, USA.
Shuyan ZhuSchepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Department of Ophthalmology, Boston, MA, USA.
Kathryn PateCoruna Medical, LLC, Longmont, CO, USA.
Jia YinSchepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Department of Ophthalmology, Boston, MA, USA. Jia_Yin@meei.harvard.edu.ORCID 0000-0003-1340-6758
Massachusetts Eye and Ear Infirmary · USNova Medical (United States) · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
CLC NIH HHS C0000008NEI NIH HHS P30 EY003790
6 · The paper itself

Abstract

Chemical injuries to the eye are emergencies with limited acute treatment options other than prompt irrigation and can cause permanent vision loss. We developed a perfluorodecalin-based supersaturated oxygen emulsion (SSOE) to topically deliver high concentration of oxygen to the eye. SSOE is manufactured in hyperbaric conditions and stored in a ready-to-use canister. Upon dispensation, SSOE rapidly raises partial oxygen pressure 3 times over atmospheric level. SSOE is biocompatible with human corneal cells and safe on mouse eyes in vivo. A single topical application of SSOE to the eye after alkali injury significantly promotes corneal epithelial wound healing, decreases anterior chamber exudation, and reduces optical opacity and cataract formation in mice. SSOE treatment reduces intraocular hypoxia, cell death, leukocyte infiltration, production of inflammatory mediators, and hypoxia-inducible factor 1-alpha signaling, thus hastening recovery of normal tissue integrity during the wound healing process. Here, we show that SSOE is an effective topical therapeutic in the acute treatment of ocular chemical injuries.

Indexed as

Burns, ChemicalFluorocarbonsAnimalsEmulsionsHumansMiceOxygenEmulsionsFluorocarbonsOxygenperfluorodecalin

Identifiers

PMID36450767
PMCPMC9712419
OpenAlexW4310638962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.